Home » Topics » BioWorld

BioWorld
RSS

APPOINTMENTS AND ADVANCEMENTS

Feb. 6, 1991

LIPOSOME CO. PARTNER TESTS CARDIOVASCULAR DRUG

Feb. 6, 1991

JOHNS HOPKINS VC FUND CONSIDERS BIOTECH

Feb. 6, 1991

PCR TAGS MAY HELP FINGER OIL SPILLERS

Feb. 6, 1991

EARNINGS REPORTS

Feb. 5, 1991

CELL GENESYS SEEKS 'UNIVERSAL' CELL

Feb. 5, 1991

THREE BIOTECH COMPANY STOCKS FLY HIGH

Feb. 5, 1991

PROPOSED BUDGET INTRODUCES FDA CHARGES

Feb. 5, 1991

NIH SAYS GENE THERAPY TESTS ON COURSE

Feb. 5, 1991

UNAPPROVED DRUGS IN GULF CHALLENGED

Feb. 4, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...